Latest news with #Ambiq
Yahoo
10-06-2025
- Business
- Yahoo
Ambiq Receives Frost & Sullivan's 2025 Global Company of the Year Award for Its Leadership in Healthcare Semiconductor Solutions
Ambiq recognized for pioneering energy-efficient semiconductor solutions that empower next-generation AI-enabled healthcare innovations SAN ANTONIO, June 10, 2025 /CNW/ -- Frost & Sullivan is pleased to announce that Ambiq has been awarded the 2025 Global Company of the Year Award in the semiconductor solutions for the healthcare industry for its outstanding achievements in innovation, technology advancement, and customer-centric strategy execution. This recognition highlights Ambiq's unwavering leadership in developing ultra-low power semiconductor platforms that are transforming digital health solutions and enabling AI-powered diagnostics and monitoring at the edge. Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. Ambiq excelled in both areas, demonstrating its ability to anticipate evolving market needs while consistently delivering cutting-edge products that enhance performance, energy efficiency, and scalability across healthcare and related sectors. "Ambiq's primary focus lies on delivering energy-efficient solutions with extended battery life. The company is also implementing solutions or models for AI that can enable the expansion of ultra-low power edge AI technologies," said Utkarsha Soundankar, industry analyst at Frost & Sullivan. Guided by a forward-looking growth strategy that prioritizes research and development, ecosystem collaboration, and application-specific innovation, Ambiq has successfully positioned itself at the forefront of the semiconductor market. The company's strategic agility and sustained investment in edge AI and low-power computing have enabled it to scale its technology globally while delivering targeted solutions that meet the demands of modern digital healthcare systems. Innovation is at the heart of Ambiq's operational ethos. Its Apollo System-on-Chip (SoC) series, now in its fifth generation, is setting new standards for energy efficiency in smart health devices. The Apollo510 combines an Arm Cortex-M55 CPU with Helium technology, advanced security features like secureSPOT and Arm TrustZone with PUF, and dynamic graphics performance via its 2.5D GPU. The company plans to release variations of both current and next-gen Apollo SoCs to cater to customers of all sizes and their power needs for AI-enabled devices. "We are honored to be awarded the prestigious Frost & Sullivan award in Healthcare Semiconductor Solutions," says Fumihide Esaka, CEO of Ambiq. "Since our founding, we have been on a mission to enable intelligence everywhere, a mission that often aligns with our digital health customer's mission of making healthcare more accessible to everyone. We're proud to help these healthcare innovators meet this mission in making effective patient care more efficient, available, and less costly using our ultra-low power semiconductors and solutions." In addition to its Apollo series, Ambiq's suite of technologies—powered by its patented Subthreshold Power Optimized Technology (SPOT®) platform—includes the Artasie real-time clocks for power optimization, the neuralSPOT AI development kit, and heartKIT®, which enables accurate AI-driven ECG monitoring. These innovations collectively extend device battery life while supporting always-on, intelligent applications across wearables, diagnostic tools, and connected medical devices. Ambiq's unwavering commitment to customer success further strengthens its position as a partner of choice in the healthcare semiconductor space. By maintaining close collaboration with device manufacturers and solution providers, Ambiq accelerates time-to-market for new products and ensures that partners receive the technical and operational support needed for long-term success. Its partnerships with companies like CardioMedive, Smartaly, and Bravechip underscore its ability to deliver reliable, high-performance, and energy-efficient chipsets that address real-world challenges in cardiovascular monitoring, wearable diagnostics, and IoT integration. Frost & Sullivan commends Ambiq for setting a high standard in competitive strategy, execution, and market responsiveness. The company's vision, robust innovation pipeline, and customer-first culture are shaping the future of semiconductor technologies for healthcare and unlocking new possibilities for edge AI and intelligent diagnostics worldwide. Each year, Frost & Sullivan presents the Company of the Year Award to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. The award recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence. Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. To learn more about why Ambiq was chosen as Frost & Sullivan's Company of the Year for Healthcare Semiconductor Solutions, read the complete evaluation report here. About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact:Ashley ShreveE: About Ambiq Our mission is to enable intelligence (artificial intelligence (AI) and beyond) everywhere by delivering the lowest power semiconductor solutions. We enable our customers to deliver artificial intelligence compute at the edge where power consumption challenges are the most profound. Our technology innovations, built on the patented and proprietary subthreshold power optimized technology (SPOT), fundamentally deliver a multi-fold improvement in power consumption over traditional semiconductor designs. We've powered over 270 million devices today. For more information, visit Contact Charlene WanVP of Marketing and Investor Relationscwan@ View original content: SOURCE Frost & Sullivan View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Cision Canada
10-06-2025
- Business
- Cision Canada
Ambiq Receives Frost & Sullivan's 2025 Global Company of the Year Award for Its Leadership in Healthcare Semiconductor Solutions
Ambiq recognized for pioneering energy-efficient semiconductor solutions that empower next-generation AI-enabled healthcare innovations SAN ANTONIO, June 10, 2025 /CNW/ -- Frost & Sullivan is pleased to announce that Ambiq has been awarded the 2025 Global Company of the Year Award in the semiconductor solutions for the healthcare industry for its outstanding achievements in innovation, technology advancement, and customer-centric strategy execution. This recognition highlights Ambiq's unwavering leadership in developing ultra-low power semiconductor platforms that are transforming digital health solutions and enabling AI-powered diagnostics and monitoring at the edge. Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. Ambiq excelled in both areas, demonstrating its ability to anticipate evolving market needs while consistently delivering cutting-edge products that enhance performance, energy efficiency, and scalability across healthcare and related sectors. "Ambiq's primary focus lies on delivering energy-efficient solutions with extended battery life. The company is also implementing solutions or models for AI that can enable the expansion of ultra-low power edge AI technologies," said Utkarsha Soundankar, industry analyst at Frost & Sullivan. Guided by a forward-looking growth strategy that prioritizes research and development, ecosystem collaboration, and application-specific innovation, Ambiq has successfully positioned itself at the forefront of the semiconductor market. The company's strategic agility and sustained investment in edge AI and low-power computing have enabled it to scale its technology globally while delivering targeted solutions that meet the demands of modern digital healthcare systems. Innovation is at the heart of Ambiq's operational ethos. Its Apollo System-on-Chip (SoC) series, now in its fifth generation, is setting new standards for energy efficiency in smart health devices. The Apollo510 combines an Arm Cortex-M55 CPU with Helium technology, advanced security features like secureSPOT and Arm TrustZone with PUF, and dynamic graphics performance via its 2.5D GPU. The company plans to release variations of both current and next-gen Apollo SoCs to cater to customers of all sizes and their power needs for AI-enabled devices. "We are honored to be awarded the prestigious Frost & Sullivan award in Healthcare Semiconductor Solutions," says Fumihide Esaka, CEO of Ambiq. "Since our founding, we have been on a mission to enable intelligence everywhere, a mission that often aligns with our digital health customer's mission of making healthcare more accessible to everyone. We're proud to help these healthcare innovators meet this mission in making effective patient care more efficient, available, and less costly using our ultra-low power semiconductors and solutions." In addition to its Apollo series, Ambiq's suite of technologies—powered by its patented Subthreshold Power Optimized Technology (SPOT®) platform—includes the Artasie real-time clocks for power optimization, the neuralSPOT AI development kit, and heartKIT®, which enables accurate AI-driven ECG monitoring. These innovations collectively extend device battery life while supporting always-on, intelligent applications across wearables, diagnostic tools, and connected medical devices. Ambiq's unwavering commitment to customer success further strengthens its position as a partner of choice in the healthcare semiconductor space. By maintaining close collaboration with device manufacturers and solution providers, Ambiq accelerates time-to-market for new products and ensures that partners receive the technical and operational support needed for long-term success. Its partnerships with companies like CardioMedive, Smartaly, and Bravechip underscore its ability to deliver reliable, high-performance, and energy-efficient chipsets that address real-world challenges in cardiovascular monitoring, wearable diagnostics, and IoT integration. Frost & Sullivan commends Ambiq for setting a high standard in competitive strategy, execution, and market responsiveness. The company's vision, robust innovation pipeline, and customer-first culture are shaping the future of semiconductor technologies for healthcare and unlocking new possibilities for edge AI and intelligent diagnostics worldwide. Each year, Frost & Sullivan presents the Company of the Year Award to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. The award recognizes forward-thinking organizations that are reshaping their industries through innovation and growth excellence. Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry. To learn more about why Ambiq was chosen as Frost & Sullivan's Company of the Year for Healthcare Semiconductor Solutions, read the complete evaluation report here. About Frost & Sullivan For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, megatrends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact: E: [email protected] About Ambiq Our mission is to enable intelligence (artificial intelligence (AI) and beyond) everywhere by delivering the lowest power semiconductor solutions. We enable our customers to deliver artificial intelligence compute at the edge where power consumption challenges are the most profound. Our technology innovations, built on the patented and proprietary subthreshold power optimized technology (SPOT), fundamentally deliver a multi-fold improvement in power consumption over traditional semiconductor designs. We've powered over 270 million devices today. For more information, visit Contact Charlene Wan VP of Marketing and Investor Relations [email protected] +1.512.879.2850 SOURCE Frost & Sullivan
Bahrain News Gazette
04-03-2025
- Business
- Bahrain News Gazette
Ambiq Democratizes Edge AI with the Apollo330 Plus Series SoCs
Ambiq Democratizes Edge AI with the Apollo330 Plus Series SoCs AUSTIN, Texas, March 04, 2025 (GLOBE NEWSWIRE) — Ambiq ®, a leading provider of ultra-low-power semiconductor solutions that address the significant power consumption challenges of conventional and AI compute at the edge, unveils the Apollo330 Plus System-on-Chip (SoC) series. The series consists of the base Apollo330 Plus, the Apollo330B Plus, and the Apollo330M Plus, each offering a rich set of peripherals and connectivity options for healthcare, smart homes and buildings, industrial edge applications, and more to drive always-on and real-time AI at the edge. Key Features: Up to 250 MHz Arm ® Cortex ® -M55 application processor with turboSPOT ® and Arm ® Helium technology 48/96 MHz Arm Cortex-M4F network processor and multi-protocol radio (in wireless product options) Over 16x faster performance and lower latency, and 30x better AI energy efficiency than similar solutions based on previous generation Cortex-M processors Ultra-low power digital microphone PDM for truly always-on voice Multiple package and connectivity options such as Bluetooth ® Low Energy, Matter, and Thread for diverse edge devices The Apollo330 Plus series is purpose-built to enable always-on and real-time AI inferencing on devices. Built on Ambiq's proprietary subthreshold power optimized technology (SPOT ®) platform, it achieves unprecedented 16x faster performance and up to 30x better AI energy efficiency compared to similar solutions based on previous generation Cortex-M processors, so manufacturers can deliver innovative features while extending device lifetimes, offering multi-protocol connectivity across diverse endpoints, and enhancing user experiences. The Apollo330 Plus architecture fully leverages the Arm Cortex-M55 processor with Arm Helium technology for AI acceleration, processing up to 8 MACs per cycle. The Apollo330 Plus series includes 2MB of on-chip system RAM, 2MB of embedded non-volatile memory, a large 32kB I-cache and 32kB D-cache on a wide bus, and a multi-protocol radio for developers to create high-performing and power-efficient products. ' While today's smart devices rely heavily on power-hungry cloud computing, the Apollo330 Plus series creates a brand-new opportunity by enabling true edge AI processing,' says Fumihide Esaka, CEO of Ambiq. ' This empowers manufacturers to create longer-lasting, more responsive, intelligent devices for homes, offices, and factories. ' ' With a growing number of new and compelling edge AI applications emerging across markets including industrial and smart home, enabling ultra-low-power AI processing directly at the edge will be transformative, ' said Laurence Bryant, VP segment marketing, IoT Line of Business at Arm. ' With this new solution, built on Arm, Ambiq is paving the way for smarter, more efficient devices that can deliver real-time intelligence across a wide range of use cases. ' The Apollo330 Plus series offers three variants: The Apollo330 Plus base model without wireless connectivity offers a rich set of peripherals for wearables, medical/healthcare, and smart home, empowering developers to create sophisticated sensor-based applications easily. The Apollo330 B Plus extends upon the Apollo330 Plus with Bluetooth ® Low Energy (BLE) support for a wide selection of connected peripherals and audio applications The Apollo330 M Plus further adds multi-protocol radio support for IEEE 802.15.4, Thread, and Matter, enabling low-power interoperability mesh networking between next-gen smart home, smart meter, and industrial edge devices Its streamlined multi-core architecture comprises a powerful application processor and a dedicated network co-processor for uncompromised radio performance. The design simplifies development while delivering uncompromised multi-protocol radio performance with robust signal strength up to +14dBm signal strength and enhanced radio sensitivity. Innovative secureSPOT ® 3.0 features based on Arm TrustZone ® technology further enhance Apollo330 Plus Series SoCs, ensuring the integrity and confidentiality of data transmitted and processed by connected devices. With hardware-based security mechanisms, such as secure boot and secure firmware updates, these SoCs provide robust protection against unauthorized access and malicious attacks, enabling secure deployment in various applications. As the newest addition to Ambiq's portfolio, the Apollo330 Plus SoC series sets a new standard for ultra-low-power AI processing at the edge. With more connectivity, security, a wider set of peripheral interfaces, and multiple package options, these SoCs provide developers with the tools they need to implement sophisticated, energy-efficient AI solutions in edge devices. Check out the Apollo330 Plus SoC Series, and visit Ambiq at Embedded World 2025 by booking a meeting with their team. About Ambiq Our mission is to enable intelligence (artificial intelligence (AI) and beyond) everywhere by delivering the lowest power semiconductor solutions. We enable our customers to deliver artificial intelligence compute at the edge where power consumption challenges are the most profound. Our technology innovations, built on the patented and proprietary subthreshold power optimized technology (SPOT), fundamentally deliver a multi-fold improvement in power consumption over traditional semiconductor designs. We've powered over 260 million devices today. For more information, visit Contact
